Literature DB >> 26041007

Deep brain stimulation of anterior nucleus thalami disrupts sleep in epilepsy patients.

Berthold R Voges1, Friedhelm C Schmitt2, Wolfgang Hamel3, Patrick M House1, Christian Kluge2,4, Christian K E Moll5, Stefan R Stodieck1.   

Abstract

In view of the regulatory function of the thalamus in the sleep-wake cycle, the impact of deep brain stimulation (DBS) of the anterior nucleus thalami (ANT) on sleep was assessed in a small consecutive cohort of epilepsy patients with standardized polysomnography (PSG). In nine patients treated with ANT-DBS (voltage 5 V, frequency 145 Hz, cyclic mode), the number of arousals during stimulation and nonstimulation periods, neuropsychiatric symptoms (npS), and seizure frequency were determined. Electroclinical arousals were triggered in 14.0 to 67.0% (mean 42.4 ± SD 16.8%) of all deep brain stimuli. Six patients reported npS. Nocturnal DBS voltages were reduced in eight patients (one patient without npS refused) and PSGs were repeated. Electroclinical arousals occurred between 1.4 and 6.7 (mean 3.3 ± 1.7) times more frequently during stimulation periods compared to nonstimulation periods; the number of arousals positively correlated with the level of DBS voltage (range 1 V to 5 V) (Spearman's rank coefficient 0.53121; p < 0.05). No patient experienced seizure deterioration and four patients reported remission of npS. This case-cohort study provides evidence that ANT-DBS interrupts sleep in a voltage-dependent manner, thus putatively resulting in an increase of npS. Reduction of nocturnal DBS voltage seems to lead to improvement of npS without hampering efficacy of ANT-DBS. Wiley Periodicals, Inc.
© 2015 International League Against Epilepsy.

Entities:  

Keywords:  Depression; Epilepsy monitoring unit; Insomnia; Memory; Polysomnography

Mesh:

Year:  2015        PMID: 26041007     DOI: 10.1111/epi.13045

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  25 in total

Review 1.  Deep Brain Stimulation for Epilepsy: Biomarkers for Optimization.

Authors:  Katrina L Dell; Mark J Cook; Matias I Maturana
Journal:  Curr Treat Options Neurol       Date:  2019-09-26       Impact factor: 3.598

2.  Responsive Neurostimulation and Cognition.

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2016 Mar-Apr       Impact factor: 7.500

3.  Electrical brain stimulation and continuous behavioral state tracking in ambulatory humans.

Authors:  Filip Mivalt; Vaclav Kremen; Vladimir Sladky; Irena Balzekas; Petr Nejedly; Nicholas M Gregg; Brian Nils Lundstrom; Kamila Lepkova; Tereza Pridalova; Benjamin H Brinkmann; Pavel Jurak; Jamie J Van Gompel; Kai Miller; Timothy Denison; Erik K St Louis; Gregory A Worrell
Journal:  J Neural Eng       Date:  2022-02-08       Impact factor: 5.043

4.  DyNeuMo Mk-1: Design and pilot validation of an investigational motion-adaptive neurostimulator with integrated chronotherapy.

Authors:  Mayela Zamora; Robert Toth; Francesca Morgante; Jon Ottaway; Tom Gillbe; Sean Martin; Guy Lamb; Tara Noone; Moaad Benjaber; Zachary Nairac; Devang Sehgal; Timothy G Constandinou; Jeffrey Herron; Tipu Z Aziz; Ivor Gillbe; Alexander L Green; Erlick A C Pereira; Timothy Denison
Journal:  Exp Neurol       Date:  2022-01-10       Impact factor: 5.620

Review 5.  Sleep, Circadian Rhythms, and Epilepsy.

Authors:  Joseph T Daley; Jennifer L DeWolfe
Journal:  Curr Treat Options Neurol       Date:  2018-09-27       Impact factor: 3.598

Review 6.  Emerging technologies for improved deep brain stimulation.

Authors:  Hayriye Cagnan; Timothy Denison; Cameron McIntyre; Peter Brown
Journal:  Nat Biotechnol       Date:  2019-09-02       Impact factor: 54.908

7.  REM Sleep Microstates in the Human Anterior Thalamus.

Authors:  Péter Simor; Orsolya Szalárdy; Ferenc Gombos; Péter Przemyslaw Ujma; Zsófia Jordán; László Halász; Loránd Erőss; Dániel Fabó; Róbert Bódizs
Journal:  J Neurosci       Date:  2021-04-16       Impact factor: 6.167

Review 8.  Directions of Deep Brain Stimulation for Epilepsy and Parkinson's Disease.

Authors:  Ying-Chang Wu; Ying-Siou Liao; Wen-Hsiu Yeh; Sheng-Fu Liang; Fu-Zen Shaw
Journal:  Front Neurosci       Date:  2021-06-14       Impact factor: 4.677

9.  ASSFN Position Statement on Deep Brain Stimulation for Medication-Refractory Epilepsy.

Authors:  Abhijeet Gummadavelli; Dario J Englot; Jason M Schwalb; Chengyuan Wu; Jorge Gonzalez-Martinez; Joseph Niemat; Jason L Gerrard
Journal:  Neurosurgery       Date:  2022-05-01       Impact factor: 5.315

Review 10.  Technology of deep brain stimulation: current status and future directions.

Authors:  Joachim K Krauss; Nir Lipsman; Tipu Aziz; Alexandre Boutet; Peter Brown; Jin Woo Chang; Benjamin Davidson; Warren M Grill; Marwan I Hariz; Andreas Horn; Michael Schulder; Antonios Mammis; Peter A Tass; Jens Volkmann; Andres M Lozano
Journal:  Nat Rev Neurol       Date:  2020-11-26       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.